| UniProt ID | GMPR2_HUMAN | |
|---|---|---|
| UniProt AC | Q9P2T1 | |
| Protein Name | GMP reductase 2 {ECO:0000255|HAMAP-Rule:MF_03195} | |
| Gene Name | GMPR2 {ECO:0000255|HAMAP-Rule:MF_03195} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 348 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides. [PubMed: 12009299] | |
| Protein Sequence | MPHIDNDVKLDFKDVLLRPKRSTLKSRSEVDLTRSFSFRNSKQTYSGVPIIAANMDTVGTFEMAKVLCKFSLFTAVHKHYSLVQWQEFAGQNPDCLEHLAASSGTGSSDFEQLEQILEAIPQVKYICLDVANGYSEHFVEFVKDVRKRFPQHTIMAGNVVTGEMVEELILSGADIIKVGIGPGSVCTTRKKTGVGYPQLSAVMECADAAHGLKGHIISDGGCSCPGDVAKAFGAGADFVMLGGMLAGHSESGGELIERDGKKYKLFYGMSSEMAMKKYAGGVAEYRASEGKTVEVPFKGDVEHTIRDILGGIRSTCTYVGAAKLKELSRRTTFIRVTQQVNPIFSEAC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Ubiquitination | PHIDNDVKLDFKDVL CCCCCCCCCCHHHHH | 45.24 | - | |
| 13 | Acetylation | NDVKLDFKDVLLRPK CCCCCCHHHHHCCCC | 46.74 | 19608861 | |
| 13 | Ubiquitination | NDVKLDFKDVLLRPK CCCCCCHHHHHCCCC | 46.74 | 19608861 | |
| 20 | Ubiquitination | KDVLLRPKRSTLKSR HHHHCCCCCCCCCCC | 53.17 | - | |
| 26 | Phosphorylation | PKRSTLKSRSEVDLT CCCCCCCCCCCCCCC | 44.12 | 28857561 | |
| 28 | Phosphorylation | RSTLKSRSEVDLTRS CCCCCCCCCCCCCEE | 49.41 | 23401153 | |
| 31 | Acetylation | LKSRSEVDLTRSFSF CCCCCCCCCCEEEEE | 37.97 | 19608861 | |
| 33 | Phosphorylation | SRSEVDLTRSFSFRN CCCCCCCCEEEEECC | 21.58 | 23403867 | |
| 35 | Phosphorylation | SEVDLTRSFSFRNSK CCCCCCEEEEECCCC | 21.73 | 24719451 | |
| 37 | Phosphorylation | VDLTRSFSFRNSKQT CCCCEEEEECCCCCE | 25.25 | 23927012 | |
| 44 | Phosphorylation | SFRNSKQTYSGVPII EECCCCCEECCCCEE | 24.32 | 27251275 | |
| 46 | Phosphorylation | RNSKQTYSGVPIIAA CCCCCEECCCCEEEE | 36.38 | 24719451 | |
| 53 | Phosphorylation | SGVPIIAANMDTVGT CCCCEEEECCCCCCH | 11.06 | 24719451 | |
| 55 | Phosphorylation | VPIIAANMDTVGTFE CCEEEECCCCCCHHH | 3.81 | 24719451 | |
| 184 | Phosphorylation | KVGIGPGSVCTTRKK EECCCCCCCCCCCCC | 19.70 | 28857561 | |
| 187 | Phosphorylation | IGPGSVCTTRKKTGV CCCCCCCCCCCCCCC | 27.72 | 27050516 | |
| 188 | Phosphorylation | GPGSVCTTRKKTGVG CCCCCCCCCCCCCCC | 35.05 | 28857561 | |
| 202 | Phosphorylation | GYPQLSAVMECADAA CCCHHHHHHHHHHHH | 2.74 | 27251275 | |
| 223 | Phosphorylation | IISDGGCSCPGDVAK EEECCCCCCCHHHHH | 26.99 | - | |
| 263 | Phosphorylation | IERDGKKYKLFYGMS EEECCCEEEEEEECC | 19.19 | 22817901 | |
| 263 | Acetylation | IERDGKKYKLFYGMS EEECCCEEEEEEECC | 19.19 | 19608861 | |
| 267 | Phosphorylation | GKKYKLFYGMSSEMA CCEEEEEEECCHHHH | 23.50 | 22817901 | |
| 270 | Phosphorylation | YKLFYGMSSEMAMKK EEEEEECCHHHHHHH | 20.84 | 22817901 | |
| 277 | Ubiquitination | SSEMAMKKYAGGVAE CHHHHHHHHCCCCEE | 27.52 | - | |
| 278 | Phosphorylation | SEMAMKKYAGGVAEY HHHHHHHHCCCCEEE | 12.64 | 29496907 | |
| 285 | Phosphorylation | YAGGVAEYRASEGKT HCCCCEEEECCCCCE | 11.18 | 25884760 | |
| 291 | Ubiquitination | EYRASEGKTVEVPFK EEECCCCCEEEECCC | 45.40 | 19608861 | |
| 291 | Malonylation | EYRASEGKTVEVPFK EEECCCCCEEEECCC | 45.40 | 26320211 | |
| 291 | Acetylation | EYRASEGKTVEVPFK EEECCCCCEEEECCC | 45.40 | 19608861 | |
| 298 | Ubiquitination | KTVEVPFKGDVEHTI CEEEECCCCCHHHHH | 48.40 | - | |
| 298 | Acetylation | KTVEVPFKGDVEHTI CEEEECCCCCHHHHH | 48.40 | 23749302 | |
| 309 | Acetylation | EHTIRDILGGIRSTC HHHHHHHHHHHHHHC | 6.35 | 19608861 | |
| 314 | Phosphorylation | DILGGIRSTCTYVGA HHHHHHHHHCCHHCH | 26.39 | 21406692 | |
| 315 | Phosphorylation | ILGGIRSTCTYVGAA HHHHHHHHCCHHCHH | 10.06 | 21406692 | |
| 317 | Phosphorylation | GGIRSTCTYVGAAKL HHHHHHCCHHCHHHH | 22.72 | 21406692 | |
| 318 | Phosphorylation | GIRSTCTYVGAAKLK HHHHHCCHHCHHHHH | 10.07 | 28152594 | |
| 332 | Phosphorylation | KELSRRTTFIRVTQQ HHHHCCCCEEEHHHC | 18.43 | 27282143 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GMPR2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GMPR2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GMPR2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SC24C_HUMAN | SEC24C | physical | 22863883 | |
| GMPR1_HUMAN | GMPR | physical | 26186194 | |
| SNX17_HUMAN | SNX17 | physical | 26186194 | |
| SNX17_HUMAN | SNX17 | physical | 28514442 | |
| GMPR1_HUMAN | GMPR | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13 AND LYS-291, AND MASSSPECTROMETRY. | |